Haematologica, Vol 92, Issue 7, 982-985 doi:10.3324/haematol.11161
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurnik, K.
Right arrow Articles by Nowak-Göttl, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurnik, K.
Right arrow Articles by Nowak-Göttl, U.

Disorders of Hemostasis

Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children – results of a multicenter study

Karin Kurnik, Wolfhart Kreuz, Sylvia Horneff, Christine Düring, Rosemarie Schobess, Christoph Bidlingmaier, Carmen Escuriola Ettingshausen, Anne Krümpel, Nadia Bogdanova, Ulrike Nowak-Göttl

From the Dept. of Pediatrics, University Hospital Munich, Germany (KK, CB); Dept. of Pediatric Hematology and Oncology, University Hospital Frankfurt, Germany (WK, CEE); Dept. of Pediatrics, University Hospital Halle/Saale, Germany (SH, RS); Dept. of Pediatric Hematology and Oncology, University Hospital Münster, Germany (CD, AK, UN-G); Institute of Medical Genetics, University of Münster, Germany (NB)

Correspondence: Ulrike Nowak-Göttl, Dept. of Pediatric Hematology/Oncology, University Children’s Hospital of Münster Albert-Schweitzer-Str. 33, 48149 Münster, Germany. E-mail: leagottl{at}uni-muenster.de

The present multicenter cohort study of 107 pediatric PUPs was performed to determine whether the concomitant inheritance of the factor (F) V G1691A or the F II G20210A mutation influences the clinical expression of severe hemophilia A (HA). Carriers of the FV and FII mutations had a significantly lower annual bleeding frequency (ABF) than non-carriers (p=0.012). Joint damage (Pettersson score) was significantly less severe in patients with thrombophilia (p=0.022). A protective effect of thrombophilic risk factors was shown for ABF (OR [CIs]: 0.7[0.5–0.9]; p=0.02) and the severity of the hemophilic arthropathy (OR [CIs]: 0.06[0.01–0.3]; p=0.0009).

Key words: severe hemophilia A, pediatric PUPs, thrombophilia, Pettersson score, synovitis.




This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
M. C. Ar, O. Baykara, A. N. Buyru, and Z. Baslar
The Impact of Prothrombotic Mutations on Factor Consumption in Adult Patients with Severe Hemophilia
Clinical and Applied Thrombosis/Hemostasis, December 1, 2009; 15(6): 660 - 665.
[Abstract] [PDF]